The association of genes involved in the angiogenesis-associated signaling pathway with risk of anterior cruciate ligament rupture

Journal of Orthopaedic Research

Volumn 32, Issue 12, 2014, Pages 1612-1618

  Rahim, Masouda ^a   Gibbon, Andrea ^a   Hobbs, Hayden ^b   Van Der Merwe, Willem ^b   Posthumus, Michael ^a   Collins, Malcolm ^a   September, Alison V ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

ACL rupture risk; Hypoxia inducible factor 1a; Kinase insert domain receptor; Nerve growth factor; Vascular endothelial growth factor

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; NERVE GROWTH FACTOR; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANTERIOR CRUCIATE LIGAMENT RUPTURE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; HYPOXIA INDUCIBLE FACTOR 1ALPHA GENE; KNEE LIGAMENT SURGERY; MAJOR CLINICAL STUDY; MALE; NERVE GROWTH FACTOR GENE; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; VASCULOTROPIN A GENE; VASCULOTROPIN RECEPTOR 2 GENE; ANTERIOR CRUCIATE LIGAMENT; GENETICS; RISK; RUPTURE;

ANTERIOR CRUCIATE LIGAMENT; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENOTYPE; HAPLOTYPES; HUMANS; MALE; RISK; RUPTURE; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84911430283     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.22705     Document Type: Article

References (25)

1. Beye JA, Hart DA, Bray RC, et al. 2008. Injury-induced changes in mRNA levels differ widely between anterior cruciate ligament and medial collateral ligament. Am J Sports Med 36:1337-1346.
2. Pufe T, Petersen W, Tillmann B, et al. 2001. The angiogenic peptide vascular endothelial growth factor is expressed in foetal and ruptured tendons. Virchows Arch 439:579-585.
3. Petersen W, Varoga D, Zantop T, et al. 2004. Cyclic strain influences vascular endothelial growth factor (VEGF) and the hypoxia inducible factor 1 alpha (HIF-la) in tendon fibroblasts. J Orthop Res 22:847-853.
4. Carmeliet P, Ferreira V, Brier G, et al. 1996. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380:435-439.
5. Shalaby F, Rossant J, Yamaguchi TP, et al. 1995. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376:62-66.
6. Wang Y, Tang Z, Xue R, et al. 2011. Combined effects of TNF-a, IL-1b and HIF-1a on MMP-2 production in ACL fibroblasts under mechanical stretch: an in vitro study. J Orthop Res 29:1008-1014.
7. Wang Y, Tang Z, Xue R, et al. 2012. Differential response to CoCl2-stimulated hypoxia on HIF-1a, VEGF, and MMP-2 expression in ligament cells. Mol Cell Biochem 360:235-242.
8. Posthumus M, Collins M, van der Merwe L, et al. 2012. Matrix metalloproteinase genes on chromosome 11q22 and the risk of anterior cruciate ligament (ACL) rupture. Scand J Med Sci Sports 22:523-533.
9. Mannion S, Mtintsilana A, Posthumus M, et al. 2014. Genes encoding proteoglycans are associated with the risk of anterior cruciate ligament ruptures. Br J Sports Med (in press).
10. Marshall S, Padua D, McGrath M. Incidence of ACL injuries. In: Hewett T, Shultz S, Griffin L, 2007. Understanding and preventing noncontact ACL injuries. Champaign, IL, USA: Human Kinetics; 5-30.
11. Posthumus M, September AV, O'Cuinneagain D, et al. 2009. The COL5A1 gene is associated with increased risk of anterior cruciate ligament ruptures in female participants. Am J Sports Med 37:2234-2240.
12. Flynn R, Pedersen C, Birmingham T, et al. 2005. The familial predisposition toward tearing the anterior cruciate ligament: a case control study. Am J Sports Med 33:23-28.
13. Little J, Higgins JPT, Ioannidis JPA, et al. 2009. STrengthening the REporting of Genetic Association studies (STREGA)-an extension of the STROBE statement. Eur J Clin Invest 39:247-266.
14. Lahiri DK, Nurnberger JI. 1991. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 19:5444.
15. Mokone GG, Gajjar M, September AV, et al. 2005. The guanine-thymine dinucleotide repeat polymorphism within the tenascin-C gene is associated with Achilles tendon injuries. Am J Sports Med 33:1016-1021.
16. Han SW, Kim GW, Seo JS, et al. 2004. VEGF gene polymorphisms and susceptibility to rheumatoid arthritis. Rheumatology 43:1173-1177.
17. Brogan IJ, Khan N, Isaac K, et al. 1999. Novel polymorphisms in the promoter and 5' UTR regions of the human vascular endothelial growth factor gene. Hum Immunol 60:1245-1249.
18. Shahbazi M, Fryer AA, Pravica V, et al. 2002. Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection. J Am Soc Nephrol 13:260-264.
19. Wang H, Keiser JA. 1998. Vascular endothelial growth factor upregulates the expression of matrix metalloprotei-nases in vascular smooth muscle cells: role of flt-1. Circ Res 83:832-840.
20. Nell E-M, van der Merwe L, Cook J, et al. 2012. The apoptosis pathway and the genetic predisposition to Achilles tendinopathy. J Orthop Res 30:1719-1724.
21. Pasternak B, Aspenberg P. 2009. Metalloproteinases and their inhibitors-diagnostic and therapeutic opportunities in orthopedics. Acta Orthop 80:693-703.
22. Lambrechts D, Storkebaum E, Morimoto M, et al. 2003. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat Genet 34:383-394.
23. Wang Y, Zheng Y, Zhang W, et al. 2007. Polymorphisms of KDR gene are associated with coronary heart disease. J Am Coll Cardiol 50:760-767.
24. Posthumus M, September AV, Cuinneagain DO, et al. 2010. The association between the COL12A1 gene and anterior cruciate ligament ruptures. Br J Sports Med 44:1160-1165.
25. Fain JS. 2006. Release of Interleukins and Other Inflammatory Cytokines by Human Adipose Tissue Is Enhanced in Obesity and Primarily due to the Nonfat Cells. Vitam Horm 74:443-477.